Journal of Clinical Oncology

The Journal of Clinical Oncology (JCO) is a medical journal published 3 times a month (36 issues a year) by the American Society of Clinical Oncology (ASCO), with a 2010 impact factor of 18.970. JCO now accounts for nearly one in 10 of all oncology journal citations. This journal s focus is work that relates to the care of patients with cancer, e.g., clinical oncology. This journal publishes in varying formats. Original research reports are both a communication tool and reports for original research. Review articles can describe work that builds on previous original research, summarize the current state clinical oncology, or can be a point of critical analysis. Opinion is voiced in editorial formats, which include commentary and discuss controversies. There is also a format for perspectives from a person of public notoriety. Special articles are another form of communication besides original research reports, which promulgate guidelines, summaries of consensus, and other scholarly communications. Fundamental research is covered in the "Biology of Neoplasia" section.

Publisher
American Society of Clinical Oncology
Impact factor
18.372 (2011)
Some content from Wikipedia, licensed under CC BY-SA

Enoxaparin prevents VTEs in advanced pancreatic cancer

(HealthDay)—For patients with advanced pancreatic cancer (APC), enoxaparin is effective for prevention and treatment of venous thromboembolic events (VTEs), according to a study published online May 18 in the Journal of ...

May 20, 2015
popularity7 comments 0

Multimodal strategy improves ovarian cancer detection

(HealthDay)—Screening with a multimodal strategy (MMS), in which annual serum cancer antigen 125 (CA-125) is interpreted with the risk of ovarian cancer algorithm (ROCA), improves detection of invasive epithelial ovarian ...

May 14, 2015
popularity12 comments 0

Interferon not beneficial for most stage III melanoma

Final results for the Sunbelt Melanoma Trial, published online this month in the Journal of Clinical Oncology, show that thanks to current diagnostic techniques, most stage III melanoma patients do not benefit from treatment ...

Feb 15, 2016
popularity247 comments 0

Non-surgical management of rectal cancer increasing

(HealthDay)—Use of nonoperative management (NOM) of rectal cancer is increasing, but primarily in disadvantaged patients, according to a study published online March 28 in the Journal of Clinical Oncology.

Mar 31, 2016
popularity0 comments 0